New Biosimilar Guidelines to ease Bioequivalence Study Norms: DCGI, ETPharma
New Delhi: The upcoming guidance for the development and manufacturing of biosimilar drugs in India will reduce the…
Govt saves over RM900m from generic medicines push, says Dzulkefly
BUTTERWORTH, Jan 24 — The government has successfully saved over RM900 million in the past two years by…